Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice

Brain

Volumn 126, Issue 7, 2003, Pages 1683-1690

  Kennedy, Peter G E ^a   Rodgers, Jean ^b   Bradley, Barbara ^b   Hunt, Stephen P ^c   Gettinby, George ^d   Leeman, Susan E ^e   De Felipe, Carmen ^f   Murray, Max ^b  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

Brain; Meningoencephalitis; Mice; Substance P; Trypanosomiasis

Indexed keywords

DIMINAZENE ACETURATE; SUBSTANCE P RECEPTOR; TACHYKININ RECEPTOR;

AFRICAN TRYPANOSOMIASIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE DISRUPTION; INFLAMMATION; KNOCKOUT MOUSE; MENINGOENCEPHALITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; SCORING SYSTEM; STIMULUS RESPONSE;

EID: 0038157077     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg160     Document Type: Article

References (25)

1. Adams JH, Graham DI. Virus and other infections. In: Adams JH, Graham DI, editors. An introduction to neuropathology. Edinburgh: Churchill Livingstone; 1998. p. 94-117.
2. Adams JH, Haller L, Boa FY, Doua F, Dago A, Konian K. Human African trypanosomiasis (T. b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy. Neuropathol Appl Neurobiol 1986; 12: 81-94.
3. Chiwakata CB, Hort G, Hemmer CJ, Dietrich M. Sera from patients with falciparum malaria induce substance P gene expression in cultured human brain microvascular endothelial cells. Infect Immun 1996; 64: 5106-10.
4. de Atouguia JLM, Kennedy PGE. Neurological aspects of human African trypanosomiasis. In: Davies LE, Kennedy PGE, editors. Infectious diseases of the nervous system. Oxford: Butterworth-Heinemann; 2000. p. 321-72.
5. de Felipe C, O'Brien JA, Palmer JA, Doyle CA, Smith AJH, Hunt SP. Characterization of the NK1 receptor knockout mouse: Alterations in nociceptive behaviour. Soc Neurosci Abstr 1997; 23: 2354.
6. de Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJH, et al. Altered nociception, analgiesia and aggression in mice lacking the receptor for substance P. Nature 1998; 392: 364-97.
7. Gichuki CW, Jennings FW, Kennedy PGE, Sommer IU, Murray M, Rodgers J, et al. The effect of azathioprine on the neuropathology associated with experimental murine African trypanosomiasis. Neurol Infect Epidemiol 1997; 2: 53-61.
8. Ho WZ, Cnaan A, Li YH, Zhao H, Lee HR, Song L, et al. Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages. AIDS Res Hum Retroviruses 1996; 12: 195-8.
9. Hunter CA, Kennedy PGE. Immunopathology in central nervous system human African trypanosomiasis. J Neuroimmunol 1992; 36: 91-5.
10. Hunter CA, Jennings FW, Kennedy PGE, Murray M. Astrocyte activation correlates with cytokine production in central nervous system of Trypanosoma brucei brucei-infected mice. Lab Invest 1992; 67: 635-42.
11. Jennings FW, Gray GD. Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes. Contrib Microbiol Immunol 1983; 7: 147-54.
12. Jennings FW, Gichuki CW, Kennedy PGE, Rodgers J, Hunter CA, Murray M, et al. The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis. Neuropathol Appl Neurobiol 1997; 23: 225-34.
13. Kennedy PGE. Overview of HIV in the nervous system. In: Scaravilli F, editor. The neuropathology of HIV infection. London: Springer-Verlag; 1993. p. 259-65.
14. Kennedy PGE. The pathogenesis and modulation of the post-treatment reactive encephalopathy in a mouse model of Human African Trypanosomiasis. J Neuroimmunol 1999; 100: 36-41.
15. Kennedy PGE, Rodgers J, Jennings FW, Murray M, Leeman SE, Burke JM. A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei. Proc Natl Acad Sci USA 1997; 94: 4167-70.
16. Lee H-R, Ho W-Z, Douglas SD. Substance P augments tumor necrosis factor release in human monocyte-derived macrophages. Clin Diagn Lab Immunol 1994; 1: 419-23.
17. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241: 1218-21.
18. Mantyh PW, Johnson DJ, Boehmer CG, Catton MD, Vinters HV, Maggio JE, et al. Substance P receptor binding sites are expressed by glia in vivo after neuronal injury. Proc Natl Acad Sci USA 1989; 86: 5193-7.
19. McGillis JP, Organist ML, Payan DG. Substance P and immunoregulation. Fed Proc 1987; 46: 196-9.
20. Murtra P, Sheasby AM, Hunt SP, de Felipe C. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 2000; 405: 180-3.
21. Pepin J, Milord F. African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis. Trans R Soc Trop Med Hyg 1991; 85: 222-4.
22. Prineas JW, McDonald WI. Demyelinating diseases. In: Graham DI, Lantos PI, editors. Greenfield's neuropathology. London: Arnold; 1997. p. 813-96.
23. Quan N, Mhlanga JD, Whiteside MB, Kristensson K, Herkenham M. Chronic sodium salicylate treatment exacerbates brain neurodegeneration in rats infected with Trypanosoma brucei. Neuroscience 2000; 96: 181-94.
24. Quartara L, Maggi CA. The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles. Neuropeptides 1998; 32: 1-49.
25. Wagner F, Fink R, Hart R, Dancygier H. Substance P enhances interferon-gamma production by human peripheral blood mononuclear cells. Regul Pept 1987; 19: 355-64.